IVD Test Reagent/Kits, Immunoassay, Autoimmune, Antiphospholipid Antibody, Cardiolipin

Definition : Immunoassay reagents intended to perform qualitative and/or quantitative analyses on a body fluid sample (e.g., serum) to determine antibodies against cardiolipin (i.e., anti-CL antibodies), an anionic phospholipid present in mitochondrial and bacterial membranes. Increased levels of anti-CL antibodies are found in some patients in a large spectrum of autoimmune diseases, including connective tissue diseases, rheumatoid arthritis, and systemic lupus erythematosus. These antibodies (particularly, some specific monoclonal antibodies) are also present in the serum of patients with the antiphospholipid syndrome; they are associated with increased risks of thrombosis and coronary and cerebral ischemic disorders.

Entry Terms : "Phosphatidylglycerol (Anti-Phospholipid Antibody) Determination Reagents" , "CL (Cardiolipin) Anti-Phospholipid Antibody Determination Reagents" , "Cardiolipin (CL) Anti-Phospholipid Antibody Determination Reagents" , "Reagents, Immunoassay, Autoimmune, Antiphospholipid Antibody, Cardiolipin"

UMDC code : 20108

U.S.companies only
Suppress Subsidiary Companies

1-6 of 6 Match(es).

Calbiotech Inc

Company Type: Parent

Calbiotech specialty is in custom design of immunoassay products for human and animal applications.

Corgenix Inc

Company Type: Parent

Corgenix is a leader in the development and manufacturing of specialized diagnostic its for immunology disorders, vascular diseases and bone and joint disorders, including the world's only non-blood-based test for aspirin effect.

Hemagen Diagnostics Inc

Company Type: Parent

Hemagen Inc. was founded in 1985 by a group of scientists from the Boston University School of Medicine.

Louisville Apl Diagnostics Inc

Company Type: Parent

Louisville APL Diagnostics, Inc. is a manufacturer and marketer of products for the in vitro detection of antiphospholipid (aPL) antibodies. These include the APhL™ ELISA Kit (CE marked and FDA cleared) and the APL™ ELISA Kit (FDA cleared) for the detection of IgG and IgM, and IgA aPL antibodies and the LAPL™ ab2GPI HRP ELISA Kit (FDA cleared) for detection of IgG, IgM, and IgA anti-b2 Glycoprotein I Antibodies. And also IgG, IgM (CE marked) and IgA Calibrators, Positive Samples and Positive Controls for anticardiolipin and ß2 Glycoprotein 1 (For Research use).

Mayo Medical Laboratories

Company Type: Parent

Zeus Scientific Inc

Company Type: Parent

ZEUS Scientific is a privately held corporation that was founded in 1976. The company began producing IFA (immunofluorescence assay) test systems followed ELISA and now multiplex (AtheNA Multi-Lyte) immunoassays. New products are developed to expand the menu which allows laboratories to run an increasing number of assays with common protocols and common reagents, as well as developing new tests to more accurately diagnose patients. In 1987 ZEUS Scientific was the first company to develop, receive appropriate regulatory clearance and bring to market a serological assay to test for Lyme disease – a condition with high prevalence in the local community where ZEUS Scientific is located.

1-6 of 6 Match(es).


Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone